Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight

NCT00741923 | Completed

• 2 other identifiers: OMAF-HEINZbeansBOW-2008
• Study Type: interventional
• Target: 14
• Locations: 1 country
• Sites: 1

Brief Summary

This project investigates the effect of regular consumption of commercially available processed white beans (5 cups per week) on food intake, body weight, blood pressure, satiety hormones and glycemic response over a 4-week period. We have chosen to provide participants with canned white beans, the most accessible and frequently consumed bean in North America. They are inexpensive, a good source of high quality nutrients and ready to eat. Based upon published literature and short-term studies conducted in our laboratory, we hypothesize that regular consumption of commercially available canned beans will increase satiety and improve the control of food intake, body weight, blood glucose and blood lipids.

Conditions

Overweight; Obesity; Metabolic Syndrome; Diabetes; Hypertension

Keywords

beans; pulses; satiety; appetite; obesity; overweight; diabetes; metabolic syndrome; hypertension; blood glucose; insulin; cholesterol; HDL; LDL; leptin; GLP-1; adiponectin; Peptide YY; diet

Outcome Measures

Primary Outcomes (1)

• body weight, waist circumference, blood glucose, satiety hormones, and blood lipids, inflammation factor, and glycated haemoglobin

  at the beginning and at the end of study

Study Arms (1)

Bean group

EXPERIMENTAL

A group consuming 5 cups/week of navy beans for a month

Other: navy beans added to regular diet

Interventions

navy beans added to regular diet OTHER

5 cups per week of commercially available white beans for 4-weeks

Also known as: Heinz beans

Bean group

Eligibility Criteria

• Age: 35 Years - 55 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• BMI 27-40 kg/m2

You may not qualify if:

• smokers and individuals who have prescribed medications over the past 6 months that could interfere with the study outcomes (i.e. statins, metformin). Breakfast skippers, those on a restricted energy diet or pregnant/lactating women

Sponsors & Collaborators

• University of Toronto: lead
• Ontario Ministry of Agriculture, Food and Rural Affairs: collaborator

Study Sites (1)

Department of Nutritional Sciences, University of Toronto

Toronto, Ontario, M5S 3E2, Canada

Location

MeSH Terms

Conditions

Overweight; Obesity; Metabolic Syndrome; Diabetes Mellitus; Hypertension; Insulin Resistance

Condition Hierarchy (Ancestors)

Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases; Endocrine System Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Harvey Anderson, Ph.D.

  University of Toronto

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: August 25, 2008
• First Posted: August 26, 2008
• Study Start: November 1, 2007
• Primary Completion: September 1, 2008
• Study Completion: December 1, 2009
• Last Updated: June 15, 2012

Record last verified: 2012-06

Locations

CA (1)